Archive for the ‘Research & Reporting’

FusionHealth to Present at the Institute for Health and Productivity Management (IHPM) International Conference

Southeastern Freight Lines to Deliver Successful Case History of Sleep Management Solutions Provided by FusionHealth

FusionHealth, the leading provider of innovative cloud-based solutions that change the way businesses think about health management, today announced that it will be presenting at the Institute for Health and Productivity Management (IHPM) International Conference in Orlando, Florida on March 26, 2013. In addition, Mr. John Pryor, Vice President of HR and Safety at Southeastern Freight Lines, Inc., a FusionHealth client and leading-edge employer regarding proactive management of sleep disorders, was invited to speak to the global attendees at the 2013 International IHPM conference about the benefits of sleep health solutions.

Southeastern Freight Lines announced the initial results and promising trends of a comprehensive analysis conducted last December by FusionHealth. The ongoing study was designed to assess the impact on health-related costs and job performance associated with effective Obstructive Sleep Apnea treatment. The study, among a cohort of commercial motor vehicle drivers, showed that within the first nine months of treatment among the sleep health program participants, medical and pharmacy cost trends decreased 6% compared to a 12-month baseline. During the same time period, the individually matched control group’s medical and pharmacy costs increased 16%.

“FusionHealth has enabled us to address the critical issue of sleep apnea and its powerful affect among our commercial drivers without a significant productivity loss to our business,” stated. Mr. Pryor. “FusionHealth’s medical acumen and business innovation made this test, and our on-going solution successful for Southeastern Freight Lines. But what surprised me most was the positive feedback that we received from our associates and their families in such a short period of time,” he shared. “The FusionHealth solution has changed people’s lives. Our associates feel better and have more energy. That just makes good business sense.”

Click below to view the full report or read it on PRWeb

FusionHealth’s Chief Medical Officer Discussing the Dangers of Sleep Apnea

Jeffrey Durmer, MD PhD, was recently the featured expert on CNN’s Daily Dose. Dr. Durmer is the Chief Medical Officer of FusionHealth. During the short segment, Dr. Durmer discussed the dangers associated with Sleep Apnea. Sleep Apnea is a condition that plagues nearly 28 million Americans. When you sleep, the muscles that regulate your normal breathing pattern relax. For some, this relaxation causes the upper airway to collapse. When this collapse occurs, your airway is closed off and breathing is temporarily interrupted. A small collapse may result in light snoring; however, a full collapse results in a complete closure of your airway and prevents breathing. Constant interruptions in your normal sleep cycles can cause various health issues because the body and brain do not get the sleep necessary for cell rejuvenation.

FusionHealth’s Chief Medical Officer Discussing the Hidden Dangers of Snoring

Jeffrey Durmer, MD PhD, was recently the featured expert on CNN’s Daily Dose. Dr. Durmer is Chief Medical Officer FusionHealth.  During the short segment, Dr. Durmer discussed the dangers associated with a snoring bed partner. According to the National Sleep Foundation, 1 out of 4 American couples sleep in separate beds. One reason for 25% of couples sleeping separately is snoring. Disruptive and restless partners, while annoying, should not be dismissed. Multiple studies have shown that snoring is an early warning sign for other health issues.

Dr. Durmer Featured in ASAA Briefing on New Sleep Technologies

Teleconference Highlights for Upcoming Economic and Clinical Impact of Sleep Apnea on the Workplace Conference

On October 4th, Edward Grandi, the Executive Director for the nonprofit American Sleep Apnea Association, and FusionHealth’s Chief Medical Officer, Jeffrey Durmer, MD PhD, held a briefing via teleconference highlighting the key points that will be offered at the 2012 conference The Economic and Clinical Impact of Sleep Apnea: A Solutions Conference for Employers and Health Plans. The briefing discussed presenters as well as subjects that will be covered in this year’s conference. Main highlights include the use of new technologies to not only treat employee Obstructive Sleep Apnea, but to also manage employee compliance wirelessly with cloud-based software. Click below to listen to the 20 minute briefing.

Briefing Highlights and Key Points:

This year’s conference will be held on October 24th & 25th in Baltimore, MD. This conference is the only one of its type with the industry’s leading experts from universities, employers and solutions providers. There is still time to register for this event at

Focus: Economic consequences of Obstructive Sleep Apnea for employers, & and solutions with quantifiable benefits for OSA diagnosis and treatment.

Keynote Speaker: Dr. Cary Shames, Chief Medical Director for the Americas, ResMed Corp., presents: Undiagnosed, Untreated, Unsustainable: The Economics of OSA

Education Presentations Include:

  • Indira Gurubhagavatula, MD University of Pennsylvania Educational: OSA Basics & Current Research
  • Sigurjon Kristjansson, FusionHealth®: The Business Requirements for Technology Based Solutions
  • Jeffery Durmer, MD PhD, FusionHealth®: Data from the New Wave of Employer Fatigue Management and Performance Programs
  • Kevin Potts Union Pacific, Chief Operating Officer at Union Pacific Health System: Case Study outlining management/treatment of Sleep Apnea and its economic results

Therapies/Treatment Presentations Include:

  • David Rapoport, MD New York University: Positive Airway Pressure for Sleep Apnea
  • Stacy Ishman, MD Johns Hopkins University: Sleep Surgery: Its Role in the Treatment of OSA
  • Michael Simmons, DMD Sleep Dentist: Oral Appliance Therapy

The conference concludes with a roundtable discussion with the experts detailing the next steps for employers.

An Exhibit Hall will offer a variety of resources with information on new solutions and technologies for employers and health plans.

Additional information is available at the conference’s website:

FusionHealth CMO Delivers OSA Case Study Trucking to Industry Executives

Dr. Jeffrey Durmer Shares 7 Lessons Every Company Should Apply to Its Sleep Management Program

At this year’s Healthy Trucking Summit in Atlanta, GA, Dr. Jeffrey Durmer, Chief Medical Officer, FusionHealth, presented invaluable information focusing on Sleep Management programs and their benefits for the trucking industry.

7 Lessons Video


A portion of the full presentation included the 7 lessons every company should apply to its Sleep Management Program.

Dr. Durmer on CNN Health Minute

Dr. Durmer, Chief Medical Officer of FusionSleep, was featured on CNN and Headline News worldwide about Delayed Sleep Phase Syndrome (DSPS) and the available therapies.


National Conference to Address Impact of Sleep Apnea on Commercial Driver’s Health & Safety

The American Sleep Apnea Association (ASAA) today announced plans to conduct a first-ever national conference on sleep apnea and trucking.  While sleep apnea is a major health and safety concern for all transportation modes, studies have shown that as many as 28 percent of commercial drivers may be afflicted by the illness.Obstructive sleep apnea (OSA) is a condition in which an individual’s airway is blocked while sleeping, typically resulting in frequent breathing interruptions lasting from10 seconds to more than a minute at a time, loud snoring and non-restorative sleep.  OSA afflicts at least 20 million Americans …equal to or more than asthma or diabetes, yet more than 85% remain undiagnosed. Individuals with OSA are more likely to have high blood pressure, heart problems, stroke, depression and sexual dysfunction and their annual health care costs are twice that of people without sleep apnea. A controlled study demonstrated that people with OSA have a six times greater risk of being involved in a traffic crash and a seven times greater risk of having multiple crashes.”The meeting’s objectives are to provide a common understanding of OSA diagnosis and treatment, clarify current and proposed regulations, create a forum of experts to generate guidance for improvements, and provide trucking management attendees with a resource toolkit to improve employee health and safety as well as realize significant benefits for the company”, said Ed Grandi, ASAA Executive Director. The first government agencies, organizations and companies to participate in this effort include: Federal Motor Carrier Safety Administration (FMCSA), American Trucking Associations (ATA), Owner- Operator Independent Drivers Association (OOIDA), National Transportation Safety Board (NTSB), Schneider National and ResMed Corporation, among others to be announced. Although commercial drivers are believed to be particularly at-risk for OSA, addressing the problem has been a challenge. “Considering the perceived expense associated with diagnosis and treatment, the potential loss of income for drivers, and the need for additional research and thoughtful regulation, the issue becomes quite complex”, Grandi explained. “By convening this meeting, great strides can be made to overcome some of the stumbling blocks that have prevented further progress”, Grandi added.

While many trucking companies are uncertain about the impact of sleep apnea on the health and safety of their drivers, a number of leading companies have taken steps to get their drivers diagnosed and treated while realizing significant health, safety and financial benefits.  Don Osterberg, Senior VP, Safety at Schneider National said, “Schneider National believes that we have a moral obligation as a company to operate the safest fleet we possibly can put out on the road. As far as a return on investment, we’ve found that not only have we reduced crash frequency and severity, we’ve improved fleet retention. We’ve seen dramatic reductions in health care costs with drivers after they’ve been diagnosed and treated.”

With presentations and panel discussions on the central issues associated with sleep apnea and trucking, ASAA seeks to establish an ongoing forum that will enable trucking, health and policy groups to work together to manage a health and safety concern that needs more awareness and focused effort.

The one-day conference will be held on Wednesday May 12 at The Westin Baltimore Washington – BWI in Baltimore and is preceded by a reception and keynote address from NTSB Chairman Deborah Hersman on Tuesday, May 11.

Early Success in Sleep Trials with J.B. Hunt Transport Services, Inc.

Early Success in Sleep Trials with J.B. Hunt Transport Services, Inc. SleepSafeDrivers, Inc., a national provider of sleep apnea diagnosis and treatment programs for fleets, today announced positive preliminary results from a clinical trial focused on testing and treating fatigue management for truck drivers with sleep apnea as part of a national contract with J.B. Hunt Transport Services, Inc. The clinical trial is a collaborative effort among J.B. Hunt, SleepSafeDrivers, Inc., and FusionSleep LLC, Georgia’s leading provider of clinical sleep medicine services to patients and employers.

The goal of the trial, which is backed by an Independent Review Board, is to improve the health and safety of the drivers. The trial results will document any cost savings from reduced medical expenses and lower accidents as a consequence of the program. J.B. Hunt is accelerating the pace of the trial and expects to continue expanding the program over time.

“We are committed to enhancing the safety and health of our drivers, and SleepSafeDrivers is helping us get that done,” said Greer Woodruff, Senior Vice President of Corporate Safety and Security at J.B. Hunt. “One of our Million Mile drivers recently told us that he felt the sleep apnea program had literally saved his life. After starting APAP therapy, that driver has lost 115 pounds, knocked out his challenging and chronic daytime fatigue, and was able to begin exercising again for the first time in years. There is absolutely no doubt that he is healthier and safer as a result of the program.”

“We are proud to be helping J.B. Hunt deliver on their goal of improving the health of their drivers while also reducing avoidable risk and expenses,” stated Dana Voien, president of SleepSafeDrivers. “Working with our clinical partners at FusionSleep in Atlanta, we are confident that fleets will recognize a four to ten month payback period on the program investment, so it more than pays for itself in the first year alone. Our national network assures that we can cover a fleet’s entire needs across the nation.”

“The goal of the trial is to quantify the health benefits and document changes in fatigue-related accidents and safety as a consequence of this unique program. Preliminary findings already demonstrate real and significant health benefits, and we anticipate that this research will provide us with the most comprehensive data and cost-effective model for disease and accident prevention in the trucking industry”, said Jeffrey Durmer, MD, PhD, and Chief Medical Officer of FusionSleep and principal investigator of the clinical trial.